These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4190097)

  • 41. [Fibrinolysis as the cause of postoperative hemorrhage in surgical practice].
    Mester E; Detky B; Füsy J
    Zentralbl Chir; 1967; 92(26a Pt 1):1429-32. PubMed ID: 5595670
    [No Abstract]   [Full Text] [Related]  

  • 42. Screening for coagulation defects.
    Morrison FS
    J La State Med Soc; 1973 Sep; 125(9):321-5. PubMed ID: 4760129
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosis and treatment of intravascular coagulation.
    Weiss AE; Cederbaum AI
    Am Fam Physician; 1973 Nov; 8(5):110-9. PubMed ID: 4746015
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapeutic problems of disseminated intravascular coagulation.
    Sherman LA; Wessler S; Avioli LV
    Arch Intern Med; 1973 Sep; 132(3):446-53. PubMed ID: 4783026
    [No Abstract]   [Full Text] [Related]  

  • 46. Detection and impact of hyperfibrinolysis in trauma.
    Schöchl H; Voelckel W; Solomon C
    Wien Klin Wochenschr; 2010 Dec; 122 Suppl 5():S11-3. PubMed ID: 21598439
    [No Abstract]   [Full Text] [Related]  

  • 47. [Blind spots of the diagnostic hemostasis screen].
    Levi M; Peters M; Briët E
    Ned Tijdschr Geneeskd; 2000 Mar; 144(10):457-60. PubMed ID: 10726152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of antifibrinolytic agents in obstetrics].
    Vojta M
    Cesk Gynekol; 1970 Jul; 35(6):384-6. PubMed ID: 5311001
    [No Abstract]   [Full Text] [Related]  

  • 49. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical studies on alpha 2-macroglobulin. Serum antifibrinolytic activity and alpha 2-macroglobulin].
    Ando H
    Nihon Naika Gakkai Zasshi; 1970 Apr; 59(4):329-39. PubMed ID: 5462888
    [No Abstract]   [Full Text] [Related]  

  • 51. [Determination of serum inhibitors of fibrinolysis by the method of "standard clots"].
    Daver J; Albugues MJ; du Pasquier JP; Ricoeur M
    Pathol Biol (Paris); 1970; 18(11):687-94. PubMed ID: 4247466
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hemorrhages caused by hyperfibrinolysis and their treatment].
    Teofili MT; Tucci G
    Clin Ter; 1968 Sep; 46(6):563-84. PubMed ID: 4914362
    [No Abstract]   [Full Text] [Related]  

  • 53. [Thromboplastic and fibrinolytic activity of the tissues of pregnant uterus and the elements of fertilized ovum].
    Vdovina GF; Skipetrov VP; Azbukina LN
    Vopr Okhr Materin Det; 1975 Jun; 20(6):75-9. PubMed ID: 1136329
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Experimental studies and clinical observations on the antifibrinolytic and hemostyptic effect of Epsilon-Tachostypan].
    Egli H; Schröder F
    Dtsch Zahn Mund Kieferheilkd Zentralbl Gesamte; 1968 May; 50(9):386-404. PubMed ID: 5252696
    [No Abstract]   [Full Text] [Related]  

  • 57. [Antifibrinolytic agents and anticoagulants in disseminated intravascular coagulation, with particular regard to embolism of the amniotic fluid and hemorrhage in gynecology].
    Koutský J
    Cesk Gynekol; 1971 Apr; 36(3):140-1. PubMed ID: 5314511
    [No Abstract]   [Full Text] [Related]  

  • 58. [Prophylactic treatment in obstetric hypocoagulability].
    Corral FS; González S; Inocente JM
    Rev Clin Inst Matern Lisb; 1967; 18(70):225-32. PubMed ID: 5631944
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antithrombin and antiplasmin effect of 4-amidinophenylpyruvic acid in vivo].
    Markwardt F; Klöcking HP; Nowak G
    Thromb Diath Haemorrh; 1970 Oct; 24(1):240-7. PubMed ID: 5483964
    [No Abstract]   [Full Text] [Related]  

  • 60. [Hematology in childhood].
    Exadaktylos P
    Z Arztl Fortbild (Jena); 1970 Sep; 64(17):891-6. PubMed ID: 5481873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.